SINCERE: Safety in Idiopathic Arthritis: NSAIDs and Celebrex Evaluation Registry A Prospective Observational Registry Of Patients With Juvenile Idiopathic Arthritis (JIA) Treated With NSAIDs.

Trial Profile

SINCERE: Safety in Idiopathic Arthritis: NSAIDs and Celebrex Evaluation Registry A Prospective Observational Registry Of Patients With Juvenile Idiopathic Arthritis (JIA) Treated With NSAIDs.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2013

At a glance

  • Drugs Celecoxib; Nonsteroidal anti-inflammatories
  • Indications Juvenile rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SINCERE
  • Sponsors Pfizer
  • Most Recent Events

    • 05 Jun 2012 Actual patient number changed from 276 to 275 as reported by ClinicalTrials.gov.
    • 07 Mar 2012 Planned end date changed from 1 Apr 2015 to 1 Jan 2012 as reported by ClinicalTrials.gov.
    • 07 Mar 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top